calendar

3 catalysts · 2 phase readout · 1 8k filing · 1 earnings

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

matching 'CRISPR'×type: phase readout×type: 8k filing×clear all

type

phase readout2
8k filing1
earnings1

therapy area

no tagged catalysts yet

Week of Aug 3, 2026

›Aug 3, 20268k filing

35d ago

$CRSP — CRISPR Therapeutics AG (CRSP) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗

Date TBD

›COMPLETEDphase readoutNCT06594094: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Sponsor: HuidaGene Therapeutics Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophin (DMD)

full page →ctgov ↗

›COMPLETEDphase readoutNCT06492304: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

Sponsor: CRISPR Therapeutics. Phase: PHASE1. Conditions: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia

full page →ctgov ↗